What the US Food and Drug Administration has cleared, approved and recalled on this topic, and the side effects people report.
Each number has its full source under its own list below.
1 new medicines approved (since 1 Jan 2023). Medicines with a new active ingredient that the FDA approved, whose label lists a use on this topic.
Approved for: JOURNAVX is indicated for the treatment of moderate to severe acute pain, including postoperative pain, in adults. JOURNAVX is a sodium channel blocker indicated for the treatment…
Source: openFDA, Novel drug approvals (new molecular entities and new biologics), since 1 Jan 2023. Retrieved 12 Nov 2026.
35 recalls (since 1 Jan 2023). Recalls of medicines for this topic, newest first.
Reason: Labeling: Incorrect or Missing Lot and/or Exp Date. Incorrect expiration date printed on the label.
Reason: Failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH).
Reason: Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.
Reason: Presence of Particulate Matter: Hair was found in products
Reason: Presence of Particulate Matter: Hair was found in products
Reason: Presence of Particulate Matter: Hair was found in products
Reason: Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
Reason: Crystallization; identified as Buprenorphine free base
Source: openFDA, Drug recall enforcement reports, since 1 Jan 2023. Retrieved 12 Nov 2026.
82 recalls (since 1 Jan 2023). Recalls of medical devices for this topic, newest first.
Reason: Therapy Disc (TD) that powers and sends stimulation signals to an Implantable Pulse Generator (IPG), part of a neurostimulation system, has a firmware issue that causes the TD to attempt to restart,…
Reason: Kits may exhibit open seals in sterile pouch packaging. Open seal may compromise product sterility. If not detected prior to use, issue may lead to contamination of sterile field or patient infection…
Reason: Kits containing Sodium Chloride ampules subject to another recall are recalled due to potentially compromised sterility.
Reason: Downstream recall - manufacturer recalled specific lots of BD ChloraPrep Clear - 1mL Applicators. Affected product may exhibit an open or incomplete seal on the packaging of the applicator. Use of po…
Reason: Windstone Medical Packaging recalled specific items and lots of AMS convenience kits containing Elevaris Lidocaine HCl injection USP. Elevaris Medical Devices Inc. recalled the Lidocaine HCl injectio…
Reason: Spinal cord stimulation system lead body may be exposed to stress at the anchor site. This may result in high impedance measurements or lead fractures, which may lead to inadequate stimulation, addit…
Reason: The kits containing Huons Lidocaine HCL Injection USP 1% 10mg/ml 5mL Ampules (Lidocaine Ampules)(OEM). A recall notice was issued by Huons Co., Ltd. for Lidocaine Ampules due to quality issues identi…
Reason: Inadvertent distribution of sealed pouches that had not undergone validated sterilization.
Reason: Sterile anchors my lack sterility assurance.
Reason: Medline kits were distributed containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP, which was subsequently recalled due to quality issues, including microbiology testing data integri…
Source: openFDA, Medical device recalls, since 1 Jan 2023. Retrieved 12 Nov 2026.
16 devices cleared (since 1 Jan 2023). Devices the FDA cleared to sell in the US, newest first.
Company: Gebauer Company
Company: Basic Medical Technology, Inc.
Company: Basic Medical Technology, Inc.
Company: Basic Medical Technology, Inc.
Company: Basic Medical Technology, Inc.
Company: Wuhan Guangdun Technology Co.,Ltd..
Company: Guangzhou Xinbo Electronic Co., Ltd.
Source: openFDA, Premarket notifications (510(k)) cleared, since 1 Jan 2023. Retrieved 12 Nov 2026.
78,548 side effect reports (reports received since 1 Jan 2023). The reactions named most often in reports about medicines used for this topic.
Anyone can send a report. A report does not prove that the medicine caused the reaction, and the counts do not show how often it happens.
Source: openFDA, FDA Adverse Event Reporting System (FAERS), reports by reaction, reports received since 1 Jan 2023. Retrieved 12 Nov 2026.
Worldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View reportAcuitas market sizes and forecasts are only in our full reports. How we use public data.